Legislature must regulate the role of drug benefit managers in our health care – The Boston Globe

College students who came of age during the COVID-19 pandemic and the Supreme Court’s decision to overturn Roe v. Wade acknowledge two very important things: first, access to high-quality health care is not something to be taken for granted, and second, geography matters. Unfortunately, these are lessons I learned from early childhood, when I developed juvenile arthritis after contracting a seemingly harmless virus, parvo, which triggers an immune reaction that triggers the condition in less than 1 percent of patients. As a result, while most 20-somethings are concerned with access…

Read More

Merck sues Biden administration over Medicare drug pricing talks

Merck is suing the Department of Health and Human Services over Medicare’s new powers to reduce drug prices under the Inflation Reduction Act. In a scathing complaint filed in federal district court, Merck criticized the negotiation process as a “false” and “amounting to extortion.” Merck has asked the US District Court for the District of Columbia to prevent HHS from forcing the company into a deal that cuts prices. Jakub Porzycki | Nur picture | Getty Images Global drugmaker Merck on Tuesday sued the Biden administration over Medicare’s new powers…

Read More

Lawyers to apply for Harry’s visa application to see drug-taking answers

Lawyers will challenge the US government today in a Washington DC federal courtroom over its decision not to disclose why Prince Harry was allowed into the country despite an admission of illegal drug use. The Heritage Foundation, a conservative political research group, has filed a lawsuit against the Department for Homeland Security (DHS) in an attempt to determine whether the correct procedure was followed in the decision to allow the Duke of Sussex to enter the United States. Under US law, an admission of drug use may be grounds for…

Read More

‘Groundbreaking’ lung cancer drug cuts risk of death in half, says ‘exciting’ study.

ALUNGcancerdrug available on the NHS halves the risk of death, according to a study. Scientists say exciting study results show osimertinib will increase survival of thousands of British patients. 2 One study found that a lung cancer drug halves the risk of deathCredit: Getty 2 Osimertinib, sold under the name Tagrisso, is already available on the NHS for some patients It works by blocking vital receptors that allow cancer cells to use up energy to grow. The medicine is already being used for some NHS patients after previous research found…

Read More

AstraZeneca’s new UK lung cancer drug hailed as a ‘game changer’

AstraZeneca’s new UK lung cancer drug is hailed as a ‘game changer’ that can HALF the risk of death By Kate Pickles Updated: 5:43 PM EDT, June 4, 2023 Research has shown that a ‘breakthrough’ British drug can halve the risk of dying from lung cancer. The groundbreaking study found that patients who received osimertinib after surgery were 51 percent more likely to be alive five years later than those given a dummy pill. The daily tablets target non-small cell lung cancer (NSCLC) cancers among people who have a specific…

Read More